Open AccessGut microbial composition in patients with psoriasis
Author(s) -
Francisco M. Codoñer,
A. Ramírez-Boscá,
Eric Climent,
Miguel A Carrión-Gutiérrez,
Mariano Guerrero,
Jose Manuel Pérez-Orquín,
José Horga de la Parte,
Salvador Genovés,
Daniel Ramón,
Vicente Navarro-López,
Empar Chenoll
Publication year - 2018
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/s41598-018-22125-y
Subject(s) - microbiome , psoriasis , metagenomics , population , medicine , biology , immunology , bioinformatics , genetics , environmental health , gene
Since the last 5–10 years the relevance of the gut microbiome on different intestinal illnesses has been revealed. Recent findings indicate the effect of gut microbiome on certain dermatological diseases such as atopic dermatitis. However, data on other skin diseases such as psoriasis are limited. This is the first time attempting to reveal the gut microbiome composition of psoriatic patients with a prospective study including a group of patients with plaque psoriasis, analyzing their gut microbiome and the relationship between the microbiome composition and bacterial translocation. The microbiome of a cohort of 52 psoriatic patients (PASI score ≥6) was obtained by 16s rRNA massive sequencing with MiSeq platform (Illumina inc, San Diego) with an average of 85,000 sequences per sample. The study of the gut microbiome and enterotype shows from the first time a specific “psoriatic core intestinal microbiome” that clearly differs from the one present in healthy population. In addition, those psoriatic patients classified as belonging to enterotype 2 tended to experience more frequent bacterial translocation and higher inflammatory status (71%) than patients with other enterotypes (16% for enterotype 1; and 21% for enterotype 3).